- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02589379
Ultrasound Elastography for Prediction of Postoperative Pancreatic Fistula (PMPPOPF)
The Value of Endoscopic Ultrasound Elastography for Prediction of Pancreatic Fistula in Patients Undergoing Pancreatic Resection for Benign or Malignant Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
One of the most generally accepted causes of postoperative pancreatic fistula (POPF) is soft texture of the pancreas. The stiffness of organs depends on histologic features such as content of fat, fibrotic tissue and micro vascular structures. Yet, pancreatic stiffness was evaluated only subjectively. Endoscopic ultrasonography (EUS) and magnetic resonance imaging (MRI) may allow objective quantification of pancreatic stiffness prior to surgery.
Endoscopic ultrasound elastography (EUE) is based on real-time Doppler technology. Image colors are derived from vibration patterns which depend on the stiffness of a specific region of the investigated organ. The retrieved images could be converted into numeric matrix using a specially designed program.
Magnetic resonance imaging (MRI) is a non-invasive method for quantitatively assessing the mechanical properties of tissues based on fat tissue content.
In this trial the investigators will assess at first the value of EUE and MRI in predicting development of postoperative pancreatic fistula and in a next step the value EUE and MRI as an objective method in prediction of pancreatic stiffness.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Zurich, Switzerland, 8091
- Recruiting
- University Hospital Zurich
-
Contact:
- Henrik Petrowsky, Prof, MD
- Phone Number: +41 44 255 30 41
- Email: henrik.petrowsky@usz.ch
-
Contact:
- Dilmurodjon Eshmuminov, MD
- Phone Number: +41 44 255 11 11
- Email: dilmurodjon.eshmuminov@usz.ch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult (more than 18 years) with resectable pancreatic lesion(s)
Exclusion Criteria:
- Total pancreatectomy
- Unresectable pancreatic lesion(s)
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pancreatic Resection
All consecutive patients undergoing pancreatic resection for benign or malignant disease and meet inclusion criteria.
|
Endoscopic ultrasound elastography, intraoperative ultrasound elastography and magnet resonance imaging to asses pancreatic stiffness prior to pancreatic resection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
POPF rate (in %) as defined by the International Study Group on Pancreatic Fistula (ISGPF) in the soft versus hard pancreas group based on the median EUE stiffness measurements generated by values derived from hue histograms.
Time Frame: within the 30 days after surgery
|
within the 30 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pearson correlation coefficient between preoperative EUE measurements of pancreatic stiffness generated by values derived from hue histograms with the fat content (in %) of the resected specimen on histology.
Time Frame: within the 30 days after surgery
|
within the 30 days after surgery
|
|
|
Pearson correlation coefficient between preoperative EUE measurements of pancreatic stiffness generated by values derived from hue histograms with intra-operative ultrasound elastography measurements generated by values derived from hue histograms.
Time Frame: within the 30 days after surgery
|
within the 30 days after surgery
|
|
|
Postoperative pancreatic fistula rate (in %) as defined by the ISGPF in the soft versus hard pancreas group based on the median MRI fat measurement (in %) on histology.
Time Frame: within the 30 days after surgery
|
within the 30 days after surgery
|
|
|
Pearson correlation coefficient between preoperative MRI measurements of pancreatic fat (in %) with the fat content (in %) of the resected specimen on histology.
Time Frame: within the 30 days after surgery
|
within the 30 days after surgery
|
|
|
Postoperative pancreatic fistula rate (in %) as defined by the ISGPF in the soft versus hard pancreas group based on the surgeons assessment of stiffness on a visual analogue scale from soft (0) to hard (10) intraoperatively.
Time Frame: within the 30 days after surgery
|
within the 30 days after surgery
|
|
|
Pearson correlation coefficient between the two surgeons assessing pancreatic stiffness intraoperatively.
Time Frame: within the 30 days after surgery
|
within the 30 days after surgery
|
|
|
Intraclass correlation coefficient of the all measurements derived from EUE, IUE, MRI, surgeons assessment and histology.
Time Frame: within the 30 days after surgery
|
within the 30 days after surgery
|
within the 30 days after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Henrik Petrowsky, Prof, MD, University of Zurich
Publications and helpful links
General Publications
- Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005 Jul;138(1):8-13. doi: 10.1016/j.surg.2005.05.001.
- Lin JW, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg. 2004 Dec;8(8):951-9. doi: 10.1016/j.gassur.2004.09.044.
- Mathur A, Pitt HA, Marine M, Saxena R, Schmidt CM, Howard TJ, Nakeeb A, Zyromski NJ, Lillemoe KD. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007 Dec;246(6):1058-64. doi: 10.1097/SLA.0b013e31814a6906.
- Nathan H, Cameron JL, Goodwin CR, Seth AK, Edil BH, Wolfgang CL, Pawlik TM, Schulick RD, Choti MA. Risk factors for pancreatic leak after distal pancreatectomy. Ann Surg. 2009 Aug;250(2):277-81. doi: 10.1097/SLA.0b013e3181ae34be.
- Saftoiu A, Vilmann P, Gorunescu F, Janssen J, Hocke M, Larsen M, Iglesias-Garcia J, Arcidiacono P, Will U, Giovannini M, Dietrich CF, Havre R, Gheorghe C, McKay C, Gheonea DI, Ciurea T; European EUS Elastography Multicentric Study Group. Efficacy of an artificial neural network-based approach to endoscopic ultrasound elastography in diagnosis of focal pancreatic masses. Clin Gastroenterol Hepatol. 2012 Jan;10(1):84-90.e1. doi: 10.1016/j.cgh.2011.09.014. Epub 2011 Oct 1.
- Sato N, Yamaguchi K, Chijiiwa K, Tanaka M. Risk analysis of pancreatic fistula after pancreatic head resection. Arch Surg. 1998 Oct;133(10):1094-8. doi: 10.1001/archsurg.133.10.1094.
- Schafer M, Mullhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg. 2002 Aug;236(2):137-48. doi: 10.1097/00000658-200208000-00001.
- Watanabe H, Kanematsu M, Tanaka K, Osada S, Tomita H, Hara A, Goshima S, Kondo H, Kawada H, Noda Y, Tanahashi Y, Kawai N, Yoshida K, Moriyama N. Fibrosis and postoperative fistula of the pancreas: correlation with MR imaging findings--preliminary results. Radiology. 2014 Mar;270(3):791-9. doi: 10.1148/radiol.13131194. Epub 2013 Nov 8.
- Yeh TS, Jan YY, Jeng LB, Hwang TL, Wang CS, Chen SC, Chao TC, Chen MF. Pancreaticojejunal anastomotic leak after pancreaticoduodenectomy--multivariate analysis of perioperative risk factors. J Surg Res. 1997 Feb 1;67(2):119-25. doi: 10.1006/jsre.1996.4974.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- POPF-0134
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Fistula
-
Peking Union Medical College HospitalRecruiting
-
Changzhou Second People's Hospital affiliated with...RecruitingPostoperative Pancreatic FistulaChina
-
Wuhan Union Hospital, ChinaEnrolling by invitationDistal Pancreatectomy | Postoperative Pancreatic FistulaChina
-
Tokai UniversityEnrolling by invitationPostoperative Pancreatic Fistula Post-pancreatoduodenectomyJapan
-
Junjie XiongRecruitingPancreaticoduodenectomy | Postoperative Pancreatic FistulaChina
-
Instituto de Investigación Sanitaria AragónCompletedPancreas Disease | Fistula PancreaticSpain
-
Mansoura UniversityCompletedPancreatic Fistula After PancreaticoduodenectomyEgypt
-
Rigshospitalet, DenmarkCompletedFistula PancreaticDenmark
-
Nepal Medical College and Teaching HospitalCompletedPancreaticoduodenectomy | Distal Pancreatectomy | Postoperative Pancreatic FistulaNepal
-
Technische Universität DresdenGerman Cancer Research CenterRecruitingPeriampullary Cancer | Postoperative Pancreatic FistulaGermany
Clinical Trials on Pancreatic Resection
-
Karolinska University HospitalCompleted
-
Università Vita-Salute San RaffaeleCompletedLocally Advanced Pancreatic AdenocarcinomaItaly
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en TechnologieCompletedPancreatic Neoplasms | Pancreatic AdenocarcinomaBelgium
-
St. Antonius HospitalEnrolling by invitationMicrobial Colonization | Pancreas Adenocarcinoma | Periampullary Cancer | Pancreas Cancer | Pancreas Neoplasm | Periampullary CarcinomaNetherlands
-
Vishnevsky Center of SurgeryCompletedInsulinoma; Pancreas
-
Richard HungerMedizinische Hochschule Brandenburg Theodor FontaneCompletedVolume-Outcome Relationship in Pancreatic Surgery
-
University Medicine GreifswaldCompletedNon-focal Congenital HyperinsulinismGermany
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en Technologie; Research Foundation...CompletedAdenocarcinoma | Pancreatic Neoplasms | Monitoring, Immunologic | Neoplasm Circulating Cells | Tumor Markers, BiologicalBelgium
-
Medizinische Hochschule Brandenburg Theodor FontaneCompletedPancreas Disease
-
Methodist Health SystemRecruitingSurgery | Liver Tumor | Pancreas TumorUnited States